The Latest

Adherence and HIV Resistance Risk With Stribild

Is HIV resistance something you have to worry about? With antiretrovirals being stronger than ever and keeping people living with HIV (PLWHA) living longer than ever, resistance is a topic that worries a lot of people. We know meds are effective -- a...

By Mathew Rodriguez

Lifting the Brain Fog After 1 Month on Stribild

After only a month on Stribild, one community member shares his thoughts on the medication and why he may need to switch.

By Brad Dalton

Two New HIV Drugs Win Recommendation as Official First-Line Treatment Options

Stribild, a once-daily, single-pill regimen, and Tivicay, a recently approved integrase inhibitor, are now officially on the list of "preferred" HIV medications in official U.S. HIV treatment guidelines.

By Myles Helfand

Stribild Gets FDA Approval as New Single-Tablet Regimen

Stribild (formerly known as the Quad), a complete once-daily single-tablet regimen (STR), was approved by the FDA in August. Stribild joins Atripla and Complera as a complete HIV regimen in one pill, each taken once daily.

The FDA based approval on ...

By Enid Vazquez for Positively Aware